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Background: The optimal strategy for abdominal wall closure has been an issue of ongoing debate. Available
studies do not specifically enroll patients who undergo emergency laparotomy and thus do not consider the
distinct biological characteristics of these patients. The present randomized controlled trial evaluates the efficacy
and safety of two commonly applied abdominal wall closure strategies in patients undergoing primary emergency
midline laparotomy.
Methods/design: The CONTINT trial is a multicenter, open label, randomized controlled trial with a two-group
parallel design. Patients undergoing a primary emergency midline laparotomy are enrolled in the trial. The two
most commonly applied strategies of abdominal wall closure after midline laparotomy are compared: the
continuous, all-layer suture technique using slowly absorbable monofilament material (two MonoplusW loops) and
the interrupted suture technique using rapidly absorbable braided material (VicrylW sutures). The primary endpoint
within the CONTINT trial is an incisional hernia within 12 months or a burst abdomen within 30 days after surgery.
As reliable data on this primary endpoint is not available for patients undergoing emergency surgery, an adaptive
interim analysis will be conducted after the inclusion of 80 patients, allowing early termination of the trial if
necessary or modification of design characteristics such as recalculation of sample size.
Discussion: This is a randomized controlled multicenter trial with a two-group parallel design to assess the efficacy
and safety of two commonly applied abdominal wall closure strategies in patients undergoing primary emergency
midline laparotomy.
Trial registration: NCT00544583Background
In Germany, more than 700,000 open abdominal opera-
tions (laparotomies) are performed each year [1]. A major
surgical complication after laparotomy is abdominal fascia
dehiscence, which may appear either as an early (burst
abdomen with evisceration) or a late (incisional hernia)
complication. These patients usually undergo surgery for* Correspondence: nuh.rahbari@med.uni-heidelberg.de
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reproduction in any medium, provided the orsecondary fascial closure, which is associated with markedly
increased morbidity [2], including high recurrence rates
(up to 45%) [3]. The applied surgical strategy for abdominal
wall closure (that is, the combination of suture technique
and material) is of high relevance for the prevention of
fascia dehiscence and, moreover, constitutes the main fac-
tor directly controllable by the surgeon. However, a recent
cross-sectional study among surgeons at institutions par-
ticipating in a large multicenter trial revealed a lack of con-
sensus regarding abdominal wall closure strategies [4]. In
particular, there is uncertainty regarding optimal abdominalLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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http://www.trialsjournal.com/content/13/1/72wall closure in patients undergoing an emergency laparot-
omy. Several randomized controlled trials (RCTs) as well as
meta-analyses have addressed the issue of optimal fascia
closure in elective laparotomies [2,5-12]. Yet, there have
been no RCTs dealing exclusively with the emergency
setting. As a result, abdominal fascia closure is performed
according to the surgeon’s individual preference rather than
according to evidence-based data. The present RCT is
designed to compare the most established strategies (con-
tinuous slowly absorbable sutures and interrupted rapidly
absorbable sutures) for abdominal wall closure after mid-
line incisions for emergency laparotomy to determine the
superiority of either strategy regarding the development of
incisional hernia.Population Patients with pri
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Figure 1 Flow chart of the CONTINT trial.Methods and design
The CONTINT trial is a randomized controlled two-
group parallel superiority trial. Figure 1 shows the study
flow chart. Patients requiring an emergency primary mid-
line laparotomy are screened for inclusion into the trial
and randomized intraoperatively. The patients’ demo-
graphic data and medical history, antibiotic prophylaxis
and/or therapy, intraoperative findings, cause of periton-
itis, surgical management and source control will be
reported. Furthermore, the time needed for fascial closure,
length of fascia incision, length of remaining suture mater-
ial (continuous group) or number of sutures needed (inter-
rupted group) and the surgeon performing the abdominal
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trial (Table 1). Follow-up visits are carried out on day 30
after surgery (visit 4) and 12 months after surgery (visit
5). Follow-up data for visit 4 are collected by telephone
interview only. Patients are asked study-related questions
on pulmonary infection, wound infection or hernia. If
necessary, the general practitioner carries out a clinical
and ultrasound examination to detect a bulging hernial
sac and palpable fascia gap. Quality of life is assessed
using a validated questionnaire (SF 36W Health Survey),
which has previously been used in trials on surgical
interventions. On visit 5, a clinical and ultrasound exam-
ination is performed to assess the primary endpoint.
Patient recruitment
The study protocol was approved by the Independent
Ethics Committee, University of Heidelberg. All patients
will be informed about the purpose of the CONTINT trial,
the applied surgical strategies, and possible benefits as well
as potential risks. Screened patients who have not been
enrolled into the trial (including patients unable to give
informed consent due to any reason) will be documented in
the screening log, including the reason for non-inclusion.
In order to be eligible for the trial, patients must be older
than 18 years and have given informed consent when
undergoing primary emergency abdominal surgery. Their
expected survival time should be more than 12 months.
Patients requiring primary midline laparotomy for ischemic
or infectious disease may be included. While patients with a
previous laparotomy are excluded, patients who had previ-
ously undergone laparoscopy (except for colon resections)
or minor abdominal operations (for example, conventional
appendectomy, cholecystectomy, hysterectomy, section)
may be included. Furthermore, a septic abdominal focus
(for example, perforated stomach ulcer, perforated diver-
ticulitis) must be present.
In addition to these preoperative criteria, the septic source
must be successfully controlled and abdominal lavage must
be performed prior to intraoperative randomization. When










Eligibility criteria X X
Randomization, surgical intervention X
Clinical visit/telephone interviewc X
Quality of lifed
Safetye X X
aGender, date of birth, height (cm), weight (kg); bsmoking, diabetes mellitus, renal insu
malignant disease, American Society of Anesthesiologists score, Mannheim Peritonitis
outcome assessment, ultrasound of abdominal wall (only visit 5); dassessed by the Shosecond look operation), patients may not be included.
Patients are excluded from the trial if they are already par-
ticipating in another trial with interference of the interven-
tion and outcome of this study.
Endpoints
The primary endpoint of the CONTINT trial is a burst
abdomen within 30 days postoperatively or an incisional
hernia within 12 months after the surgery.
A burst abdomen is defined as postoperatively missing
continuity of the abdominal fascia in combination with a
wound dehiscence and/or a consecutive relapse oper-
ation occurring up to day 30 after surgery.
The endpoint ‘incisional hernia’ is assessed by a physical
examination and an abdominal ultrasound examination at
the trial center 12 months after the operation. A hernia is
present if a fascia gap and a protruding hernia sac are seen
on ultrasound and if the clinical examination is consistent
with a hernia. To guarantee independence of the outcome
assessment, the clinical and ultrasound examination needs
to be performed by a board certified surgeon familiar with
the examination of the abdominal wall, who has not been
involved in the surgical procedure of the patient. Ultrasound
examinations have to be carried out by an investigator who
has had at least six months training in this method.When a
patient’s hernia is confirmed by a surgical intervention for
an incisional hernia within 12 months after the index oper-
ation, the primary endpoint is achieved even in absence of
an ultrasound examination by the operation report.
A set of surgical and nonsurgical parameters will be
documented as secondary endpoints within the CON-
TINT trial (Table 2).
Standardized treatment
Patients’ intraoperative and perioperative treatment is
standardized except for the closure of the abdominal
wall, which is carried out according to the allocated
study intervention. Antibiotic prophylaxis and therapy is
carried out according to local standards (for example,
see [15]).Day of discharge)
4
(30 days post operation)





fficiency, chronic pulmonary impairment, immunosuppressive treatment, anemia,
Index [13], indication, surgical intervention; cclinical visit/telephone interview
rt Form (36) Health Survey (visit 4: by telephone); eserious adverse events.
Table 2 Secondary endpoints within the CONTINT trial
Secondary endpoint Definition
Length of skin incision Length of wound from the upper to the lower pole of the
skin (cm) after abdominal wall closure (skin staples in place)
Length of fascia incision Length of wound from the upper to the lower pole of the
fascia (cm) after closure of fascia
Time needed for fascial closure From the first stitch to the last knot (min)
Frequency of re-operation due to
burst abdomen
Surgical intervention indicated due to the occurrence of burst
abdomen after intervention
Frequency of re-operation Any laparotomy at any time during the follow-up period
Frequency of abdominal
re-interventions
Any puncture of the abdominal cavity (for example, computed
tomography- or ultrasound-guided drainage) at any time
during the follow-up period
Postoperative pulmonary infection Infection of the lung with either evidence of increased
infection parameters (C-reactive protein> 2 mg/dl and/or
leukocytes> 10,0000 cells/ml) that are not caused by a different
pathologic process or evidence of pulmonary infiltration in the
chest X-ray, requiring antibiotic therapy. Decrease of lung
function testing results (forced expiratory volume in 1 s and
vital capacity) by 20% or more in comparison with the baseline
lung function testing.
Duration of artificial respiration Time on the respirator postoperatively (days)
Duration of postoperative hemodialysis Time on hemodialysis (days)
Frequency of wound infection Surgical site infections within 30 days divided into superficial
and deep incisional infections according to the Centers for
Disease Control and Prevention definition [14]
Duration of vacuum therapy From first placement of the sponge to removal of the
sponge (days)
Duration of wound healing in patients
with secondary wound healing
From opening of the wound to complete skin closure (days)
Time to first bowel movement From the day of surgery until day of patient’s first bowel movement
Quality of life SF 36 filled in by the patient 30 days and 12 months after the
index operation
Duration of abdominal drainage via
intraoperatively placed drains
From the day of surgery until the day of removal of the last
intraoperatively placed drain (days)
Duration of closed abdominal lavage From the day of surgery until the last day of closed abdominal
lavage via the intraoperatively placed drains (days)
Postoperative duration of hospital stay From the day of the operation until the day of discharge (days)
Postoperative duration of intensive
care unit stay
Time from admission to the intensive care unit until transfer to
the regular ward (days)
Mortality Death due to any cause at any time during the follow-up period
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tissue and the abdominal fascia, carefully avoiding damage
to the umbilicus [16]. Opening of the abdomen is
performed with scissors and incision of the peritoneum is
completed with electric cautery. The performed surgical
intervention depends on the underlying disease and is
performed in line with local standards. In case of a septic
focus (for example, a perforated diverticulitis or perforated
gastric or duodenal ulcer), source control and abdominal
lavage are essential parts of the procedures. Abdominal
drains are placed at the end of surgery. Furthermore, drains
may be placed for postoperative continuous lavage. Creation
of a stoma is not an exclusion criterion for this trial.Trial interventions
Before closure of the abdominal wall, the length of the
fascial incision is measured (in centimeters). Then, four
Mikulicz clamps (or equivalent) are placed at the edges
of the abdominal fascia. The expertise of the surgeon
(board certified versus no certificate) present at the clos-
ure is documented.
In the continuous group, the abdomen is closed by a
continuous, all-layer suture using two MonoplusW loops,
which are made of a slowly absorbable monofilament
material. MonoplusW sutures need to be stretched once
by the assisting nurse or operation technician before use
to avoid breakage of the material. The first stitch has to
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having closed half of the wound, one end of the loop is
cut right below the needle. Then one stitch is made back
to the opposite edge of the fascia and both ends are tied
with at least four counter-rotating knots. At the caudal
end of the wound, the same procedure is done with
intersection of both loops at the middle of the incision
and overlapping of both suture lines for at least 2 cm.
Loops are not to be tied together. For every patient, two
loops must be used, irrespective of the length of the
wound. After completion of the fascial closure, the loop
will be cut directly underneath the needle. The length of
the remaining suture material has to be measured.
In the interrupted group, patients will receive abdom-
inal wall closure by interrupted sutures using VicrylW
sutures. Anchoring of stitches cranial and caudal of inci-
sion is performed in analogy to the continuous suture
group. Suturing of the abdominal wall is performed from
either end of the incision to the middle of the incision.
The number of sutures used has to be recorded. Once
all stitches are done, each suture is tied with at least four
counter-rotating knots.
For both groups, the maximum distance between
the stitches should be 1.5 cm and the distance from
the edge of the fascia should be at least 2 cm. Sub-
cutaneous tissue is not sutured and no subcutaneous
drainage is used. The skin is closed with clips and
the length of the skin incision (in centimeters) is
measured.
Assessment of safety
Occurrences of events concerning the primary or sec-
ondary endpoints are assessed as endpoints only (not
as adverse events) and are explicitly asked for.
The following conditions are expected after the initial
operation and will therefore not be classified as a com-
plication: pain, nausea, vomiting, urinary tract infection,
hyper- or hypotension, imbalances of blood sugar or
electrolytes and other laboratory values out of range, if
they are not exceeding the duration and extent that can
be expected after surgery.
From the day the patient has signed informed con-
sent until the regular end of the trial at 12 months
follow-up or until premature withdrawal of the pa-
tient, all serious adverse events (SAEs) must be
reported within 5 days after the SAE is known. The
SAE form contains the following information: identi-
fication of the trial participant, attending physician,
description of the SAE (event, beginning and dur-
ation, severity, outcome, causality to the intervention
of the trial, treatment or interventions taken), date
and signature of the attending physician.
Analysis of safety-related data will be based on these
SAE reports.Randomization and blinding
Patients will be randomized to one of the two treatment
groups just before closure of the abdominal wall using
sealed envelopes. Randomization numbers will be allocated
to the two groups in balanced permuted blocks using the
random number generator of the validated software SAS
by the Institute of Medical Biometry and Informatics
(IMBI), Heidelberg, Germany. To avoid any potential of
predicting group allocation for patients, the block length is
fixed in a separate document that is withheld from the
study site. As performed in previous studies, sealed and
opaque envelopes are produced and labeled with the
randomization number containing a data sheet that states
the group allocation for the patient with the respective
randomization number [17-19]. Randomization envelopes
will be used in consecutive order. To avoid manipulations,
a thick black bar was placed on the opposite side of the
sheet, exactly at the position where the randomization
information is located. Basic characteristics of the patient
and day of randomization are documented on the data
sheet. Thus, compliance to the randomization scheme may
be controlled retrospectively. When the study is finished,
all unopened envelopes will be sent back to the data man-
agement center where they are compared to the allocated
randomization numbers and checked for completeness.
The assessors of the CONTINT trial are blinded to the
patients’ study treatment.
Data management and monitoring
All protocol-required information collected during the
trial is entered in the case report form (CRF) by the inves-
tigator or a designated representative. Investigators are
expected to complete documentation as soon as possible
after the information is collected, preferably on the same
day that a trial participant is seen for an examination,
treatment or any other trial procedure. An explanation
must be given for all missing data.
The completed CRF must be reviewed and signed by the
investigator named in the trial protocol or by a designated
sub-investigator. After keeping a copy at the trial center,
the original CRF is sent to the IMBI for data entry. Double
data entry is carried out at the IMBI to ensure correct
transfer of data from the CRF to the database. Complete-
ness, validity and plausibility of data are examined by val-
idating programs that thereby generate queries, which
need to be clarified by the investigator. At the end of the
trial, the principle investigator will retain the original
CRFs. All data are managed and analyzed at the joint unit
of the Study Center of the German Surgical Society and
IMBI in accordance with the current standard operating
procedures of the IMBI.
Monitoring is carried out in accordance with ICH E6
(Good Clinical Practice) and standard operating proce-
dures by the Coordinating Center for Clinical Trials,
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tiation visit by the monitor, who will hand out the pre-
pared investigator site file. All relevant trial issues are
discussed and trial personnel is trained. Important issues
controlled by the monitor are availability of written
informed consent and compliance to inclusion and exclu-
sion criteria, as well as documentation of primary endpoint
and safety data. Regular contact by phone and/or email
with all participating centers will enable the monitor to
control the study progression, check adherence to the
study protocol, and discuss problems related to the study.
In addition, close-out visits are planned for each center.
Statistical consideration and sample size
Hypothesis
Within confirmation analysis, the null hypothesis tested
is that there is no difference in the incidence of burst
abdomen at 30 days postoperatively or incisional hernia
within 12 months after emergency midline laparotomy
between the two abdominal wall closure strategies under
investigation.
Interim analysis
When the study was planned, there existed no pilot data
and there was no evidence with respect to the scientific
question of the study [20]. Therefore, the values of the
parameters required for sample size calculation (overall
rate and treatment effect to be expected) were completely
unknown. Within a fixed sample size design, it was hence
uncertain whether the desired power would be achieved or
not. For that reason, the study is performed with an adap-
tive interim analysis. This design allows early stopping of
the trial or, if continued, modification of design character-
istics - such as recalculation of the sample size - under
control of the global type I error rate.
The implementation of the design is as follows: an adap-
tive interim analysis as described by Bauer and Köhne [21]
will be performed after 80 evaluable patients have com-
pleted the 12 months follow-up. The global one-sided type
I error rate of the trial is controlled by 0.025. This is
achieved by implementing the following decision rules.
The study is stopped after the interim analysis with accept-
ance of the null hypothesis if the one-sided P-value lies
above 0.40, and with rejection of the null hypothesis if the
one-sided P-value falls below 0.0115. Otherwise, the study
is continued with a second stage, and the null hypothesis
is rejected in the final analysis if the product of the stage-
wise one-sided P-values falls below 0.0038.
Data analysis
For the interim analysis as well as for the final analysis,
each patient’s allocation to the different analysis popula-
tions (full analysis set (FAS), per protocol (PP) analysis set,
safety analysis set) will be defined prior to the analysis.The allocation will be documented in the statistical ana-
lysis plan. During the data review, deviations from the
protocol will be assessed as ‘minor’ or ‘major’. Major
deviations from the protocol will lead to the exclusion of a
patient from the PP analysis set.
The null hypothesis is assessed by testing the effect of
the wall closure procedure (continuous versus interrupted)
in a logistic regression model that takes into account the
covariates body mass index (BMI; values as measured on
the original scale) and age (values as measured on the ori-
ginal scale). The decision rules according to the adaptive
design as specified above will be applied in the interim and
the final analysis, respectively.
Confirmatory analysis will be primarily based on the
FAS, which is consistent with the intention-to-treat
principle by including all patients who were randomized
to the two groups. This approach reflects the idea that
the study should match as closely as possible to the con-
ditions in clinical practice.
If a patient leaves the study prematurely, missing data
with respect to the primary outcome variable will be
replaced by the Imputed Case Analysis by incorporating
available reasons for missing data (ICA-r) method
described by Higgins et al. [22].
In addition to the evaluation of the FAS, a PP analysis
will be performed for the primary endpoint including all
randomized patients without major protocol violations.
The secondary variables will be analyzed descriptively by
tabulation of the measures of the empirical distributions
and by application of appropriate tests whose results are
to be interpreted in a strictly descriptive sense.
Determination of the sample size
The sample size calculation is based on the two-sided
chi-square test for difference for the assessment of the pri-
mary endpoint. It can be expected that taking the potential
confounders BMI and age into account in the analysis will
increase the power as compared with the chi-square test.
Due to the lack of any empirical data on the overall rate
and the treatment effect to be expected, only a preliminary
sample size calculation is performed and a sample size
reassessment is conducted in a planned adaptive interim
analysis (see above). The power for early rejection of the
null hypothesis after the first study stage with a total of 80
evaluable patients amounts to 80% if, for example, the true
incidence rates of incisional hernia or burst abdomen are
0.20 and 0.53 or 0.30 and 0.65, respectively, in the two
groups.
A sample size of 80 evaluable patients until the in-
terim analysis was therefore considered as both feasible
and sufficient to gain enough information required for
sample size recalculation in case the trial is continued
after the interim analysis. The rate of loss to follow-up
observed up to the interim analysis will also be taken
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second stage.
Discussion
The optimal strategy of abdominal wall closure after midline
laparotomy has remained an issue of ongoing discussion.
To date, various RCTs and meta-analyses on abdominal wall
closure strategies after midline laparotomy have been pub-
lished with heterogeneous results. A recent meta-analysis
identified several RCTs on techniques and materials of
abdominal wall closure after elective laparotomy [20]. While
some of the detected studies included patients who under-
went emergency laparotomy, there were no trials that
specifically enrolled patients who had emergency surgery.
The pooled analyses demonstrated a benefit of the
continuous suture technique on the development of inci-
sional hernia. Remarkably, statistical heterogeneity of the
meta-analyses increased substantially if studies that enrolled
patients with emergency laparotomy were included, whereas
there was almost no heterogeneity in the sensitivity analyses
excluding these studies. These findings suggest a significant
difference between the biological properties of and demands
to the abdominal wall of patients undergoing elective and
emergency laparotomy. Reasons for this difference have not
been clarified in detail and probably include factors such as
a contaminated operative field, poor general conditions of
these (septic) patients and different requirements to the
abdominal wall, especially in patients requiring prolonged
mechanical ventilation. In particular, the proliferation of
bacteria in tissue represents a strong risk factor causing
wound infection with delayed healing of the wound and
wound dehiscence [23]. The adverse impact of emergency
surgery on the incidence of postoperative complications as
compared to an elective setting has already been demon-
strated in various studies [24-28]. In a large cohort study
including more than 4.800 patients who underwent open
gastrointestinal surgery, emergency surgery was associated
with a significantly increased incidence of postoperative
tissue and wound complications [24]. On multivariate ana-
lysis, male gender, peritonitis, kind of operation and mul-
tiple operations were independent predictors of tissue and
wound complications in the subgroup of patients who
underwent emergency surgery.
Based on the described differences between patients
undergoing emergency and elective laparotomy as well as
the current lack of studies, there is an urgent need for pro-
spective studies specifically assessing strategies of abdom-
inal wall closure after emergency midline laparotomy The
present RCT compares the two most commonly applied
strategies of abdominal wall closure after midline laparot-
omy, that is, the continuous, all-layer suture technique
using slowly absorbable monofilament material (two
MonoplusW loops) and the interrupted suture technique
using rapidly absorbable braided material (VicrylWsutures). The incidence of burst abdomen by 30 days or
incisional hernia within 12 months after surgery was
chosen as the primary endpoint to specifically assess the
impact of both closure techniques on abdominal fascia
healing in the emergency setting. In theory, the inter-
rupted closure technique may allow discharge of
(contaminated) ascites and thus be associated with fewer
intra-abdominal complications (for example, fluid collec-
tions or abscess) as well as improved abdominal fascia
healing. However, a randomized trial is required to validly
assess superiority of this technique.
An adaptive interim analysis is performed in the CON-
TINT trial to cope with the lack of reliable data required
for a substantiated sample size calculation.
To achieve a homogenous study population, only
patients undergoing primary midline laparotomy for an
emergency indication will be included in the CONTINT
trial. Furthermore, the confirmatory analysis of the overall
treatment effect is performed using a logistic regression
model that includes patients’ BMI and age as potential
confounding factors. There is a recognized need to
standardize the definition of complications after surgical
interventions to enable comparisons of results from differ-
ent studies [29-31]. For this reason, endpoints within the
CONTINT trial have been defined a priori to minimize
assessment bias.
In conclusion, the CONTINT trial represents the first
RCT assessing efficacy and safety of two different abdom-
inal wall closure strategies in patients undergoing emer-
gency midline laparotomy. Applying high methodological
standards, the results of the trial will help to improve and
standardize surgical treatment in this specific population
of patients that may not be simply compared to patients
undergoing elective surgery.Trial implementation and status
Protocol development and trial organization
The CONTINT trial has been designed initially as a single
center RCT and was initiated at the Department of Surgery,
University of Heidelberg in November 2007. After 1.5 years
of recruitment, a total of 16 patients had been enrolled in
the study. Due to the insufficient recruitment of patients at
a single center, we decided to expand the number of trial
institutions, including distribution via the Trial Network of
the German Surgical Society (CHIR-Net). Consequently,
the trial protocol was amended and an investigators’ meet-
ing was held at Frankfurt, Germany on 31 August 2009. Up
to this date, 26 patients had been recruited.
A total of 11 trial centers have approved participation in
the CONTINT trial. A total of 73 patients have been ran-
domized at the date of submission of this paper.
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